Summary
Latest filing:
Kathleen Laporte files SEC Form 4 reports at Q32 Bio Inc. (QTTB). 15 SEC Form 4 filings on record going back to 2024, most recently on 22 July 2026. Most recent open-market trade: sold $123K of PRPO on 8 September 2025. Lifetime open-market sales: $123K.
Recent transactions
4The latest 4 SEC Form 4 transactions reported by Kathleen Laporte.
Trading pattern
InsiderAlpha's records for Kathleen Laporte go back to 2024: 15 primary Form 4 filings, an average of 5.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kathleen Laporte files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $15.00M in QTTB purchases and sales in the last 12 months
- Diyong Xu - $15.00M in QTTB purchases and sales in the last 12 months
- Jodie Pope Morrison - $286K in QTTB purchases and sales in the last 12 months
- Lee Kalowski - $115K in QTTB purchases and sales in the last 12 months
- Shelia M. Violette - $59K in QTTB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kathleen Laporte?
Kathleen Laporte is a corporate insider of Q32 Bio Inc. (QTTB). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kathleen Laporte submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Kathleen Laporte been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($123K) across all tracked filings.